| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.088 | 0.1 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |